National Research (NRC) Projected to Post Quarterly Earnings on Monday

National Research (NASDAQ:NRC) is anticipated to post its Q3 2026 results after the market closes on Monday, October 26th. Analysts expect National Research to post earnings of $0.21 per share and revenue of $35.80 million for the quarter. Individuals are encouraged to explore the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Tuesday, October 27, 2026 at 4:30 PM ET.

National Research (NASDAQ:NRC) last issued its earnings results on Tuesday, July 28th. The company reported $0.31 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.15) by $0.46. National Research had a net margin of 4.18% and a return on equity of 164.26%. The business had revenue of $35.39 million during the quarter, compared to the consensus estimate of $34.90 million. On average, analysts expect National Research to post $0.98 EPS for the current fiscal year and $1.05 EPS for the next fiscal year.

National Research Stock Up 2.6%

NRC opened at $21.93 on Friday. National Research has a 1-year low of $11.32 and a 1-year high of $23.68. The stock has a market cap of $498.91 million, a PE ratio of 87.72 and a beta of 0.25. The stock’s fifty day simple moving average is $21.10 and its 200 day simple moving average is $20.07. The company has a current ratio of 0.65, a quick ratio of 0.65 and a debt-to-equity ratio of 13.13.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Citizens Jmp lifted their target price on National Research from $23.00 to $26.00 and gave the stock a “market outperform” rating in a report on Wednesday, July 29th. Wall Street Zen downgraded shares of National Research from a “buy” rating to a “hold” rating in a research note on Saturday, August 15th. Weiss Ratings cut National Research from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, October 9th. Finally, Zacks Research upgraded shares of National Research to a “hold” rating in a research note on Monday, October 5th. One analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, National Research has an average rating of “Hold” and an average price target of $26.00.

National Research Company Profile

National Research Corporation, formerly traded on the Nasdaq under the symbol NRC, provides research, analytics and performance-improvement services to the health care industry. Through its NRC Health business, the company helps hospitals, health systems and other care organizations understand and improve patient, consumer and employee experiences.

Its offerings have included patient and employee surveys, market research, reputation management, loyalty and engagement programs, benchmarking, and software tools that turn feedback and other data into operational insights.